Eli Lilly & Co. (LLY) Tops Q1 EPS Views; Maintains Outlook
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,220.45 -0.93%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
ECX, ONON, LODE, More
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
ECX, ONON, LODE, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.24, $0.08 better than the analyst estimate of $1.16. Revenue for the quarter came in at $5.84 million versus the consensus estimate of $5.7 billion.
Maintains outlook.
Maintains outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 908 Devices Inc. (MASS) Misses Q2 EPS by 17c ; Offers Guidance
- LB Pharmaceuticals Inc (LBRX) Misses Q2 EPS by 93c
- Cardinal Health (CAH) Tops Q4 EPS by 19c, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
